|
1000
|
Abstract/Summary
|
-
AIM: This study aimed to evaluate the performance of the WELLS score for the diagnosis of pulmonary embolism in patients with COVID-19 in Souss-Massa Regional Hospital Center. This article reviewed the diagnostic accuracy of the WELLS score associated with the dosage of D-dimer biomarkers. Material and Methods: This retrospective observational descriptive and transversal study was conducted at Souss-Massa Regional Hospital Center, from March 15, 2021 to June 26, 2021. RESULTS: The study included 77 patients who underwent chest CT angiography due to oxygen desaturation associated with the values of the biological marker D -dimers. The most responsive antecedents were type II diabetes (41.00%), hypertension (17.9%), and heart disease (15.4%). The mean age of 47 patients with pulmonary embolism had an average age of 62.09 years (+/- 13.31), including 40 men (85.1%) and 7 women (14.9%); 9 patients died, with no medical history available. Comorbidity factors presented in 80.85% (38/47 cases) of patients, the most frequent being type II diabetes 44.73% (17/38 cases), arterial hypertension 28.94% (11/38), heart disease 5.26% (2/38), chronic respiratory failure 2.63% (1/38), smoking history 10.52% (4/38), asthma patients were 5.26% (2/38), and tuberculosis patients were 2.63% (1 /38). Among these patients 38.29% died. The combination of the Wells score with the value of D-dimers can be useful to guide the appropriate care for his patients. DISCUSSION: The combination of the Wells score with the value of D-dimers can be useful to guide the appropriate care for his patients.
|
